Cathryn Low
Plus aucun poste en cours
Profil
Cathryn Low has been a Commercial Real Estate Sales and Investment Advisor for Langston & Low since September 2000.
She was Chief Financial Officer of SeraCare Life Sciences, Inc. Ms. Low worked for Prolman Associates.
She was a Bankruptcy Examiner for the Bankruptcy Court in San Diego in 1999.
Ms. Low was Senior Vice President and Chief Financial Officer of Yankee Bank in Boston from November 1984 to October 1987.
Previously, she was a Certified Public Accountant for Price Waterhouse in Boston.
Ms. Low received a BA in Biological Sciences from Mount Holyoke College and an MBA in Finance and Accounting from Columbia University and is a Certified Public Accountant.
Anciens postes connus de Cathryn Low
| Sociétés | Poste | Fin |
|---|---|---|
SeraCare Life Sciences, Inc.
 SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology SeraCare Life Sciences, Inc. provides in vitro diagnostics and clinical laboratory products. It supplies diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers. The firm’s products include Next-Gen Sequencing and Digital PCR Tools, Controls and Reference Materials, Validation and Lot Qualification Materials, Plasma and Serum Diluents/Derivatives, Cell Culture Reagents, KPL Antibodies and Conjugates and KPL Immunoassay Reagents and Kits. The company was founded in 1984 and is headquartered in Milford, MA. | Directeur Financier/CFO | - |
Formation de Cathryn Low
| Mount Holyoke College | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
SeraCare Life Sciences, Inc.
SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology SeraCare Life Sciences, Inc. provides in vitro diagnostics and clinical laboratory products. It supplies diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers. The firm’s products include Next-Gen Sequencing and Digital PCR Tools, Controls and Reference Materials, Validation and Lot Qualification Materials, Plasma and Serum Diluents/Derivatives, Cell Culture Reagents, KPL Antibodies and Conjugates and KPL Immunoassay Reagents and Kits. The company was founded in 1984 and is headquartered in Milford, MA. | Health Technology |
